ArticleFrontiers in immunology2025
Case Report: Atypical anti-GBM nephritis coexisting with Henoch-Schönlein purpura nephritis: exploring the pathogenic nexus.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: While anti-glomerular basement membrane (GBM) nephritis typically manifests with circulating antibodies targeting the GBM, atypical seronegative variants may occur. Henoch-Schönlein purpura nephritis (HSPN) is characterized by IgA-dominant immune complex deposition. The simultaneous presentation of these two distinct immune-mediated glomerulopathies poses unique diagnostic and therapeutic dilemmas, with limited cases reported in the literature. Case presentation: We describe a 16-year-old female presenting with rapidly progressive glomerulonephritis and cutaneous purpura. Initial serological testing was negative for anti-GBM antibodies. Renal biopsy was performed, with light microscopy showing segmental glomerulosclerosis. Immunofluorescence demonstrated distinctive dual deposition patterns: mesangial IgA consistent with HSPN and linear IgG along with capillary walls and GBM, confirming concurrent atypical anti-GBM nephritis. The patient responded favorably to combination therapy including glucocorticoids, immunosuppressants, and plasmapheresis, with subsequent improvement in renal function and resolution of symptoms. Conclusion: This case illustrates the diagnostic challenges posed by seronegative anti-GBM nephritis with HSPN overlap, emphasizing the critical role of histopathological examination in establishing the diagnosis. Our experience supports the efficacy of early, aggressive immunosuppressive therapy in such complex presentations. These findings warrant further investigation into the possible shared pathogenic mechanisms of these two disease entities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.